1
/
of
1
ALFA INTES (IND.TER.SPLENDORE)
Idroflog Ophthalmic Solution with Sodium Hyaluronate and Hydrocortisone Sodium Phosphate, 15 Vials of 0.5 ml
Idroflog Ophthalmic Solution with Sodium Hyaluronate and Hydrocortisone Sodium Phosphate, 15 Vials of 0.5 ml
Regular price
€16,15 EUR
Regular price
€19,00 EUR
Sale price
€16,15 EUR
Taxes included.
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
MINSAN: 942605066
EAN:
DITTA: ALFA INTES (IND.TER.SPLENDORE)
IDROFLOG
Description
Ophthalmic solution containing sodium hyaluronate which, thanks to its mucomimetic and pseudoplastic properties, spreads uniformly over the ocular surface, forming a protective viscoelastic bandage. In this way, by exerting a mechanical action ("barrier effect"), IDROFLOG stabilizes the tear film and reduces the friction caused by eye movements and blinking, protecting the eye surface and promoting the repair processes following damage to corneal epithelial cells due to a hyposecretion of the tear film. In fact, in cases where the glands responsible for secreting the tear film reduce their normal activity—due to various factors—the corneal surface remains more exposed to external aggressions. Over time, these aggressions cause a malfunction of the corneal epithelial cells, associated with the risk of bothersome inflammatory processes. The application of the IDROFLOG bandage protects the corneal surface from exposure to external aggressions and, thanks to the ancillary action of Hydrocortisone Sodium Phosphate (a low-dose cortisone agent with low anti-inflammatory power and short duration of action), helps prevent the risk of possible recurrences of inflammatory phenomena.
IDROFLOG is intended for limited-time use and always under the direct supervision of a specialist doctor. Finally, thanks to its particular saline composition, IDROFLOG restores and maintains at physiological levels the concentrations of important ions, such as sodium, potassium, and magnesium, essential for the well-being of the ocular surface. The device does not contain preservatives.
Composition
Sodium hyaluronate 2 mg/ml, hydrocortisone sodium phosphate 10 mcg/ml, trisodium citrate, sodium chloride, potassium chloride, magnesium chloride, dibasic sodium phosphate, monobasic sodium phosphate, water for injections.
How to use
IDROFLOG should be dosed individually according to your condition and based on the recommendations of your ophthalmologist. In general, instill 1-2 drops of the solution into the conjunctival sac of the eye to be treated, 2-4 times a day. The total duration of treatment is 2-6 months but must be specifically determined by the specialist doctor and in any case under their direct supervision (a follow-up every 30-45 days is recommended).
Detach a single vial from the strip. Remove the top tab by twisting it.
Instill 1-2 drops into the conjunctival sac, letting them fall from above.
IDROFLOG can also be used while wearing contact lenses.
Warnings
When not to use:
- Hypersensitivity to the components or other chemically related substances;
- In conjunction with viral contamination of the ocular surface, keratitis ulcers, eye mycoses, purulent conjunctivitis, purulent and herpetic blepharitis, stye;
- Generally contraindicated during pregnancy, breastfeeding, and in pediatric age.
Due to its viscoelastic properties, the product may cause temporary blurred vision upon instillation. Wait until this effect subsides before driving vehicles or operating machinery.
IDROFLOG is for external use only.
IDROFLOG should not be used immediately before administering curative medications, and within twenty minutes after the application of any topical pharmacological therapy. If symptoms in the eyes worsen during treatment, contact a doctor as soon as possible. Prolonged use may lead to complications: the total duration of treatment must be determined by the ophthalmologist. If an inflammatory process is already underway, the specialist doctor will decide on the appropriate anti-inflammatory therapy to restore the physiological conditions of the ocular surface.
To reduce the risk of contamination during use, the aluminum pouch should only be opened immediately before product use. Avoid direct contact of the vial tip with fingers, the eye, or any other surface.
In rare cases, slight blurred vision has been observed upon instillation, which is due to the viscosity of the solution. A slight burning sensation may occur during instillation. However, this sensation is intended to disappear. Contact your ophthalmologist if symptoms persist. Adherence to the instructions in the leaflet reduces the risk of undesirable effects.
Do not use IDROFLOG after the expiry date indicated on the packaging. The expiry date refers to the intact product, correctly stored.
Keep out of sight and reach of children.
IDROFLOG should be used under the advice of a specialist doctor.
Storage
Store at a temperature between 2°C and 25°C.
Format
Pack containing 15 vials of 0.5 ml.
Ophthalmic solution containing sodium hyaluronate which, thanks to its mucomimetic and pseudoplastic properties, spreads uniformly over the ocular surface, forming a protective viscoelastic bandage. In this way, by exerting a mechanical action ("barrier effect"), IDROFLOG stabilizes the tear film and reduces the friction caused by eye movements and blinking, protecting the eye surface and promoting the repair processes following damage to corneal epithelial cells due to a hyposecretion of the tear film. In fact, in cases where the glands responsible for secreting the tear film reduce their normal activity—due to various factors—the corneal surface remains more exposed to external aggressions. Over time, these aggressions cause a malfunction of the corneal epithelial cells, associated with the risk of bothersome inflammatory processes. The application of the IDROFLOG bandage protects the corneal surface from exposure to external aggressions and, thanks to the ancillary action of Hydrocortisone Sodium Phosphate (a low-dose cortisone agent with low anti-inflammatory power and short duration of action), helps prevent the risk of possible recurrences of inflammatory phenomena.
IDROFLOG is intended for limited-time use and always under the direct supervision of a specialist doctor. Finally, thanks to its particular saline composition, IDROFLOG restores and maintains at physiological levels the concentrations of important ions, such as sodium, potassium, and magnesium, essential for the well-being of the ocular surface. The device does not contain preservatives.
Composition
Sodium hyaluronate 2 mg/ml, hydrocortisone sodium phosphate 10 mcg/ml, trisodium citrate, sodium chloride, potassium chloride, magnesium chloride, dibasic sodium phosphate, monobasic sodium phosphate, water for injections.
How to use
IDROFLOG should be dosed individually according to your condition and based on the recommendations of your ophthalmologist. In general, instill 1-2 drops of the solution into the conjunctival sac of the eye to be treated, 2-4 times a day. The total duration of treatment is 2-6 months but must be specifically determined by the specialist doctor and in any case under their direct supervision (a follow-up every 30-45 days is recommended).
Detach a single vial from the strip. Remove the top tab by twisting it.
Instill 1-2 drops into the conjunctival sac, letting them fall from above.
IDROFLOG can also be used while wearing contact lenses.
Warnings
When not to use:
- Hypersensitivity to the components or other chemically related substances;
- In conjunction with viral contamination of the ocular surface, keratitis ulcers, eye mycoses, purulent conjunctivitis, purulent and herpetic blepharitis, stye;
- Generally contraindicated during pregnancy, breastfeeding, and in pediatric age.
Due to its viscoelastic properties, the product may cause temporary blurred vision upon instillation. Wait until this effect subsides before driving vehicles or operating machinery.
IDROFLOG is for external use only.
IDROFLOG should not be used immediately before administering curative medications, and within twenty minutes after the application of any topical pharmacological therapy. If symptoms in the eyes worsen during treatment, contact a doctor as soon as possible. Prolonged use may lead to complications: the total duration of treatment must be determined by the ophthalmologist. If an inflammatory process is already underway, the specialist doctor will decide on the appropriate anti-inflammatory therapy to restore the physiological conditions of the ocular surface.
To reduce the risk of contamination during use, the aluminum pouch should only be opened immediately before product use. Avoid direct contact of the vial tip with fingers, the eye, or any other surface.
In rare cases, slight blurred vision has been observed upon instillation, which is due to the viscosity of the solution. A slight burning sensation may occur during instillation. However, this sensation is intended to disappear. Contact your ophthalmologist if symptoms persist. Adherence to the instructions in the leaflet reduces the risk of undesirable effects.
Do not use IDROFLOG after the expiry date indicated on the packaging. The expiry date refers to the intact product, correctly stored.
Keep out of sight and reach of children.
IDROFLOG should be used under the advice of a specialist doctor.
Storage
Store at a temperature between 2°C and 25°C.
Format
Pack containing 15 vials of 0.5 ml.
Share
